Please visit our MS learning channel on YouTube, which provides hundreds of MS related topics from many of our video recorded education programs and archived here: -- Be empowered with MS views and news. Opt-in with us:

~~ Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.


Wednesday, March 1, 2017

ACP Resources Help Scientists Gain New Insights Into MS Progression

Click here to receive MS news via e-mail

As we have reported in previous issues of the newsletter, ACP accelerates MS research by distributing samples and data from the Repository that many of you helped to create, to scientists studying MS. At the heart of ACP’s mission is providing resources that enable scientists to do important work that positively impacts the lives of people affected by MS. What sets us apart from other MS organizations is that we partner with hundreds of scientists, in a wide array of institutions, literally all over the globe. We think it’s impossible to predict where the next great discovery in MS treatment will be found. 

Accordingly, our resources are “open source,” meaning that we’re willing and able to invest in every MS researcher, wherever they may be. 

This is the story of one investigation, conducted by a team of nine scientists from four Australian universities and a French biotechnology company, led by 
Continue reading

MS Views and News is MAKING an IMPACT on those affected by Multiple Sclerosis

No comments: